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Abstract
Background: Dihydrofolate reductase (DHFR) and thymidylate synthase (TS) are crucial enzymes
in DNA synthesis. In alveolata both enzymes are expressed as one bifunctional enzyme.
Results: Loss of this essential enzyme activities after successful allelic assortment of knock out
alleles yields an auxotrophic marker in ciliates. Here the cloning, characterisation and functional
analysis of Tetrahymena thermophila's DHFR-TS is presented. A first aspect of the presented work
relates to destruction of DHFR-TS enzyme function in an alveolate thereby causing an auxotrophy
for thymidine. A second aspect is to knock in an expression cassette encoding for a foreign gene
with subsequent expression of the target protein.
Conclusion: This system avoids the use of antibiotics or other drugs and therefore is of high
interest for biotechnological applications.
Background
Tetrahymena thermophila is a ciliated eukaryotic unicellular
organism belonging to the regnum of protozoa and bear-
ing two nuclei, a transcriptionally silent, diploid germline
micronucleus (MIC) and a transcriptionally active, poly-
ploid somatic macronucleus (MAC)[1]. In 1923, when
Nobel Laureate Andre Lwoff succeeded in growing Tet-
rahymena in pure culture, the basis for exploiting this alve-
olate as a model organism was laid. Milestone discoveries
made in T. thermophila are the discovery of dynein
motors[2], telomeres[3], RNA-mediated catalysis[4], tel-
omerase[5] and the function of histone acetyltransferases
in transcription regulation[6]. Within the last decades
molecular biological techniques have been developed to
alter T. thermophila's genome and proteome: DNA trans-
fection methods range from microinjection[7] and elec-
troporation[8] into the MAC to biolistic bombardment of
MIC and MAC[9]. Episomal plasmids based on an rDNA-
replicon are available[10], as well as knock out/-in tech-
niques based on homologous recombination[11,12].
On protein level heterologous expression of related spe-
cies has been performed[13,14] and also endogenous pro-
teins were silenced by a novel antisense-ribosome-
technique[15]. The biotechnological potential of T. ther-
mophila has been proven in numerous publications, dem-
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Genomic structure of T. thermophila bifunctional DHFR-TS enzyme Figure 1
Genomic structure of T. thermophila bifunctional DHFR-TS enzyme. A: The DNA sequences of the gene and the 
cDNA as well as the deduced amino acid sequence are shown on the left (introns underlined, blue). B: The DHFR-TS gene 
structure of T. thermophila consists of three exons (green) and two introns (blue). C:Overview of primer pairs to amplify DNA 
for homologous integration and to amplify the CDS.
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1 atgaaaacaa gacattttga tatagtttta gcttagactt taaaaaaata gggtataggt
MKT RHF DIVL AQT LKK QGIG
61 tataagaaca gtttaccatg gagactacct aatgagctta aaaactttaa aaaaataact
YKN SLP WRLP NEL KNF KKIT
121 acagaaacta agaacaaagg cctataaaac gctgttatca tgggtaaaaa tacttgggaa
TET KNK GL-N AVI MGK NTWE
181 gcactaccta aaaagcaata accattgaaa gatcgcttaa atattgttat ttccactact
ALP KKQ QPLK DRL NIV ISTT
241 atgcaagagg ggtaaattgc agatcattcc tacgcctgta aaagcttaga ttctgcttta
MQE GQI ADHS YAC KSL DSAL
301 aactttttag aatagtaaaa ttaaatataa gatgcccttg taattggagg agctaaactt
NFL EQQ NQIQ DAL VIG GAKL
361 tgccaataag cattaagcga tcagagactt agatagattc atctaacaag agtag
CQQ ALS DQRL RQI HLT RV
421
481 gtgtcg aagttgagtg cgatgttttt atgcaaaagg actacttaaa
GV EVE CDVF MQK DYL
541 aaactttgat atgattgagg tgtctgaaac ttaaagcgaa aataatttaa attatgattt
KNFD MIE VSE TQSE NNL NYD
601 tactaggtat tttaataaga attataaagg ataagttgac ccttctctct ttaagaaaat
FTRY FNK NYK GQVD PSL FKK
661 gtacaagcct catcaagaat attaatactt agaacttatc gatgaaatta taaagaatgg
MYKP HQE YQY LELI DEI IKN
721 acatgttaaa acagacagaa ctggaactgg tacaatttct cagtttggca agttgatgag
GHVK TDR TGT GTIS QFG KLM
781 atttgactta tcaaagagtt ttcctctgct tactaccaaa aatgtttttt ggagaggtgt
RFDL SKS FPL LTTK NVF WRG
841 agtagaa
VVE
901 g
961 aacttatttg gtttatcaaa ggcagtacaa acagcaaaat actttcagaa aaaggagtta
ELI WFIK GST NSK ILSE KGV
1021 aaatatggga cggtaatggc agcagagaat ttttagatta attaggcttt aaaaacagag
KIW DGNG SRE FLD QLGF KNR
1081 aagaaggaga tttaggtcct gtttatggtt tctaatggag acacttcggt gctgaatata
EEG DLGP VYG FQW RHFG AEY
1141 aagatatgca tacaaattat aaaggtaaag gtgtcgacca gcttcaagat ttaattaaca
KDM HTNY KGK GVD QLQD LIN
1201 caataaagaa aaatcctgac agcagaagga tgattatgaa tgcctggaat gttaaagatc
TIK KNPD SRR MIM NAWN VKD
1261 taccattgat ggctttacct ccttgtcatg tcatgagcta gttttatgta aatgataata
LPL MALP PCH VMS QFYV NDN
1321 aactaagctg tatgatgtac taaagatctt gtgatatggg tttaggaata ccatttaata
KLS CMMY QRS CDM GLGI PFN
1381 tagccagtta tgctttattg actcatatga tagcttaagt cactaatatg taagttggag
IAS YALL THM IAQ VTNM QVG
1441 agtttataca tgttctaggt gatgctcatg tttactctaa tcacgtagat taactaaaaa
EFI HVLG DAH VYS NHVD QLK
1501 tttaattaga aagagctcca taccccttcc ctcttttaaa aattaataac aacaagtaat
IQL ERAP YPF PLL KINN NKQ
1561 ataactctat tgaagacttc actcttgaag atttcgaatt aattggatac aactatcacc
YNS IEDF TLE DFE LIGY NYH
1621 ctaaaatata aatgaaaatg gctgtctga
PKI QMKM AV-
tcaaaaatat ttag
gtcag
tagaattaaa tttattaaat actttctttt tatgaacaaa agagataatt aaataacttt
gta ataaatatat ttatttattt attaatttat agtttgatag atttaaaaat
gaaatttagt ctgattttta gtagaataaa taaaataatc taaatatata aattaatag
C
B
DHFR 5´1 NotI DHFR 3´1 XhoI DHFR 5´2 BamHI DHFR 3´2 Acc651
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onstrating fast growth, high biomass, fermentation in
ordinary bacterial/yeast equipment, up-scalability, exist-
ence of cheap and chemical defined media [16-18].
Although known and analysed for decades, only a few
markers have been described for T. thermophila. So far
there are ribosomal point mutation mediated resistances,
a plasmid based neomycin resistance[19] and a beta-tubu-
lin selection marker making use of an inducible promoter
in combination with mutated tubulins being resistant or
sensitive to the mitotic drug taxol[20]. Yet no true auxo-
Comparison of the T. thermophila DHFR-TS bifunctional enzyme to other protozoa Figure 2
Comparison of the T. thermophila DHFR-TS bifunctional enzyme to other protozoa. Amino acid sequence compar-
ison of Tetrahymena thermophila (Tt), Plasmodium falciparum (Pf), Plasmodium vivax (Pv), Cryptosporidium hominis (Ch), Toxoplasma 
gondii (Tg), Leishmania major (Lm) and Trypanosoma cruzi (Tc) DHFR-TS bifunctional enzyme.
Tt 1 ---------------------mktrhfdivlaqtlkkq------------------gigyknslpwrlp--------------nel-knfkkittetkn---------------kg----
Pf 1 mme------------------qvcdvfdiyaicacckvesknegkknevfnnytfrglgnkgvlpwkcnsldmkyfcavttyvnes-kyeklkykrckylnketvdnvndmpnskk----
Pv 1 me-------------------dlsdvfdiyaicacckvaptsegtknepfsprtfrglgnkgtlpwkcn--------------svdmkyfssvttyvde---------------skyekl
Ch 1 ---------------------mseknvsivvaasvlss------------------gigingqlpwsis--------------edl-kffskitnnkcd---------------sn----
Tg 1 ----------------------mqkpvclvvamtp-kr------------------giginnglpw--p--------------hlt-tdfkhfsrvtkt---------------tp----
Lm 1 msraaarfkipmpetkadfafpslrafsivva--ldmqh-----------------gigdgesipwrvp--------------edm-tffknqttllrn---------------kk----
Tc 1 msl------------------fkirmpetvaegtrlalrafslvvavdehg-----gigdgrsipwnvp--------------edm-kffrdlttklrg---------------kn----
consensus r fdIV a t k GIG k sLPW p K Fk Tt k k
Tt 48 ----------------------------------lq-----------------------------navimgkntwealpkkqqplkdrlnivisttmq---------egqia----dhsy
Pf 98 ----------------------------------lq-----------------------------nvvvmgrtswesipkkfkplsnrinvilsrtlkk--------edfde----dvyi
Pv 73 kwkrerylrmeasqgggdntsggdnthggdnadklq-----------------------------nvvvmgrsswesipkqykplpnrinvvlsktlt---------kedvk----ekvf
Ch 48 ----------------------------------kk-----------------------------nalimgrktw--dsigrrplknriivvissslp---------qdead----pnvv
Tg 44 ----------------------------------eeasrlngwlprkfaktgdsglpspsvgkrfnavvmgrktwesmprkfrplvdrlnivvssslk---------eedia----aekp
Lm 68 ----------------------------------pptekkr------------------------navvmgrktwesvpvkfrplkgrlnivlsskatveellaplpegqraaaaqdvvv
Tc 64 ----------------------------------vkpspakr-----------------------navvmgrktwdsippkfrplpgrlnvvlsstlt---------tqhll----dglp
consensus lq NAV MG TWE PkK PLk RlNiV S t e a d
Tt 92 a---------cks--------------ldsalnfleqqnq---iqdal--viggaklcqqalsdqrlrqihl-------trvgvevecdvfmq---------------------------
Pf 143 i---------nkv--------------ed--livllgkln---yykcf--iiggsvvyqeflekklikkiyf-------trinstyecdvffp---------------------------
Pv 151 i---------ids--------------idd-lllllkklk---yykcf--iiggaqvyreclsrnlikqiyf-------tringaypcdvffp---------------------------
Ch 90 v---------frn--------------ledsienlmndds---ienif--vcggesiyrdalkdnfvdriyl-------trvalediefdtyf---------------------------
Tg 117 qaegqqrvrvcas--------------lpaalslleeeyk---dsvdqifvvggaglyeaalslgvashlyi-------trvarefpcdvffpafpgddilsnkstaaqaaapaesvfvp
Lm 130 v---------ngg--------------laealrllarplycssietay--cvgga----qvyadaml------------------spcieklq---------------------------
Tc 114 d---------eekrnlhadsivavnggleqalrllaspnytpsietvy--cigggsvyaeal---rppcvhllqaiyrttirasesscsvf-----------------------------
consensus s Ld aL L i viGGa aLsd i l TRv e CdVF
Tt 150 --------kdylknfdmievs-----------etqs-----ennl--nydf---------------------------------------------------------------------
Pf 199 --------eineneyqiisvs-----------dvyt-----snnt--tldf---------------------------------------------------------------------
Pv 208 --------efdesqfrvtsvs-----------evyn-----skgt--tldflvyskvgggvdggasngstatalrrtamrstamrrnvaprtaappmgphsrangerapprararrttpr
Ch 148 --------peipetflpvyms-----------qtfc-----tkni--sydf---------------------------------------------------------------------
Tg 213 fcpelgrekdneatyrpifis-----------ktfs-----dngv--pydfvvlekrrktddaataepsnamsslts-------------------------------------------
Lm 176 --------evyltriyatapa-----------ctrffpfppenaa--tawd---------------------------------------------------------------------
Tc 191 --------------frvpesgteaaagiewqretis-----eeltsangne---------------------------------------------------------------------
consensus f i vS eT s enn yDF
Tt 175 ------------------tryfnknyk---------------------------gqvdpslf---kkm----------------------------------------------------
Pf 224 ------------------iiykktnnk---------------------------mlneqnci---kgeeknndmplknddkdtchmkkltefyknvdkykinyenddddeeeddfvyfnf
Pv 302 qrkttsctsalttkwgrktrstckilk---------------------------fttasrl-----------------------------------------------------------
Ch 173 -------------------mifekqekktlqncdpargqlksiddtvdllgeifgirkmgnr---hkf----------------------------------------------------
Tg 272 ------------------trettpvhg---------------------------lqapssaa---aia----------------------------------------------------
Lm 206 ------------------lassqgrrk---------------------------seaeglefeickyv----------------------------------------------------
Tc 223 ------------------tky--------------------------------------yfe---kli----------------------------------------------------
consensus try k K k
Tt 195 ------------------------ykp---------------------------hqeyqylelideiiknghvktdrtgtgtisqfgklmrfdlsksf-pllttknvfwrgvveeliwfi
Pf 296 nkekeeknknsihpndfqiynslkyky---------------------------hpeyqylniiydimmngnkqsdrtgvgvlskfgyimkfdlsqyf-pllttkklflrgiieellwfi
Pv 336 -------------------------mq---------------------------hpeyqylgiiydiimngnkqgdrtgvgvmsnfgymmkfnlseyf-pllttkklflrgiieellwfi
Ch 219 ------------------------pkeeiyntpsirfgre--------------hyefqyldllsrvlengayrenrtgistysifgqmmrfdmresf-pllttkkvairsifeeliwfi
Tg 292 ------------------------pvlawmdeedrkkreqkeliravphvhfrgheefqyldliadiinngrtmddrtgvgviskfgctmrysldqaf-pllttkrvfwkgvleellwfi
Lm 229 ------------------------prn---------------------------heerqylelidrimktgivkedrtgvgtislfgaqmrfslrdnrlpllttkrvfwrgvceellwfl
Tc 232 ------------------------prn---------------------------reeeqylslvdriiregnvkhdrtgvgtlsifgaqmrfslrnnrlpllttkrvfwrgvceellwfl
consensus k H EyQYL LId Ii NG vk DRTG GtiS FG MRFdLs F PLLTTK VFwRGv EEL WFI
Tt 263 kgstnskilsekgvkiwdgngsrefldqlgfknreegdlgpvygfqwrhfgaeykdmhtnykgkgvdqlqdlintikknpdsrrmimnawnvkdlplmalppchvmsqfyv-ndnk--ls
Pf 388 rgetngntllnknvriweangtrefldnrklfhrevndlgpiygfqwrhfgaeytnmydnyenkgvdqlkniinlikndptsrrillcawnvkdldqmalppchilcqfyv-fdgk--ls
Pv 403 rgetngntllnknvriweangtrefldnrklfhrevndlgpiygfqwrhfgaeytnmhdnyedkgvdqlknvihlikneptsrriilcawnvkdldqmalppchilcqfyv-fdgk--ls
Ch 300 kgdtngnhliekkvyiwsgngskeyleriglghreendlgpiygfqwrhyngeyktmhddytgvgvdqlaklietlknnpkdrrhiltawnpsalsqmalppchvlsqyyvtndnc--ls
Tg 387 rgdtnanhlsekgvkiwdknvtrefldsrnlphrevgdigpgygfqwrhfgaaykdmhtdytgqgvdqlknviqmlrtnptdrrmlmtawnpaaldemalppchllcqfyv-ndqke-ls
Lm 298 rgetsaqlladkdihiwdgngsrefldsrgltenkemdlgpvygfqwrhfgadykgfeanydgegvdqiklivetiktnpndrrllvtawnpcalqkmalppchllaqfyv-ntdtsels
Tc 301 rgetyakklsdkgvhiwddngsrafldsrglteyeemdlgpvygfqwrhfgaaythhdanydgqgvdqikaivetlktnpddrrmlftawnpsalprmalppchllaqfyv-snge--ls
consensus G TN LseKgV IWdgNGsREFLD g REe DLGPvYGFQWRHFGAeYk Mh NY GkGVDQL I tiK NP sRRmi AWNvkdL MALPPCH QFYV nD k LS
Tt 380 cmmyqrscdmglgipfniasyallthmiaqvtnmqvgefihvlgdahvysnhvdqlkiqlerapypfpllkinnnkqynsiedftledfeligynyhpkiqmkmav
Pf 505 cimyqrscdlglgvpfniasysifthmiaqvcnlqpaqfihvlgnahvynnhidslkiqlnripypfptlk--lnpdikniedftisdftiqnyvhhekismdmaa
Pv 520 cimyqrscdlglgvpfniasysifthmiaqvcnlqpaqfihilgnahvynnhvdslkvqlnripypfptlk--lnpevkniedftisdftienyvhhdkitmemaa
Ch 418 cnlyqrscdlglgspfniasyailtmmlaqvcgyepgelaifigdahiyenhltqlkeqlsrtprpfpqlk--fkrkveniedfkwedieligyypyptikmdmav
Tg 505 cimyqrscdvglgvpfniasyslltlmvahvcnlkpkefihfmgnthvytnhvealkeqlrreprpfpivnilnkerikeiddftaedfevvgyvphgriqmemav
Lm 417 cmlyqrscdmglgvpfniasyalltiliakatglrpgelvhtlgdahvyrnhvdalkaqlervphafptlifkeerqy--ledyeltdmevidyvphpaikmemav
Tc 418 cmlyqrscdmglgvpfniasyalltiliakatglrpgelvhtlgdahvysnhvepcneqlkrvprafpyl--vfrrerefledyeegdmevidyapyppismkmav
consensus CmmYQRSCDmGLG PFNIASYalLThMIAqVtn q gEfiH LGdAHVY NHVd LK QL R PyPFP Lk n IEDFt eDfE igY HpkI M MAVBMC Biotechnology 2006, 6:21 http://www.biomedcentral.com/1472-6750/6/21
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trophic marker is available that permits selection without
the use of antibiotics or drugs.
Critical enzymes in pyrimidine biosynthesis are dihydro-
folate reductase (DHFR) and thymidylate synthase (TS).
DHFR catalyses the production of tetrahydrofolate from
dihydrofolate; TS is in charge of transferring a methyl-
group from N5, N10-methylene-tetrahydrofolate to
dUMP thereby generating dTMP and tetrahydrofolate.
These enzymes being crucial for pyrimidine synthesis
have been used as auxotrophic markers in various systems
by targeted gene disruption but also a number of inhibi-
tors (antifolates) have been developed as anti-cancer
drugs[21]. In animals, fungi and eubacteria the DHFR and
TS gene are separately translated, whereas plants, alveo-
lata and euglenozoa have a bifunctional fusion gene with
both enzyme activities combined in one protein ("DHFR-
TS").
The occurrence of the bifunctional enzyme in T. pyriformis
has been postulated in 1984 and 1985 but no functional
or even molecular biological analysis had been per-
formed. A partial amino acid sequence of DHFR-TS of a
non determined "T. pyriformis-like strain" has been pub-
lished in 2002[22], but this work is lacking any proof of
linkage to the described partial cDNA to enzyme function.
Here we present a first characterization of the T. ther-
mophila DHFR-TS gene including gene structure and func-
tional data on the enzyme and data on in vivo function.
For the first time we show that the T. thermophila DHFR-
TS locus provides an auxotrophic marker system that ena-
bles monitoring of allelic assortment processes. As PCR
based approaches always have to cope with wildtype alle-
les present in the MIC, the DHFR-TS auxotrophy system is
able to deliver direct proof of the allelic assortment to be
completed: Only in the case of all wildtype alleles in the
MAC having been substituted by the knock out construct
the auxotrophy will occur. Combining this methodology
with a knock in, a new, stable and useful strain to express
recombinant enzymes or proteins has been generated.
Results
Tetrahymenathermophila is a free-living ciliated protozoan
that has become increasingly interesting as an excellent
expression system. It is one of the best characterised uni-
cellular eukaryotes and its genome has been sequenced in
its entirety (The Institute for Genomic Research[23]).
These features form the basis for using T. thermophila in
future biotechnology applications. However, appropriate
marker systems that are essential tools for genetic manip-
ulations are limited. The enzymes dihydrofolate reductase
(DHFR) and thymidylate reductase (TS) play a crucial for
pyrimidine synthesis, therefore both enzymes have been
used as auxotrophic marker-systems in various species by
targeted gene disruption. The aim was to establish such a
DHFR marker system for T. thermophila. Interestingly, the
bifunctional DHFR-TS has been as taxonomic tool to set
up phylogenetic trees for years. These approaches led to a
very rudimental DHFR-TS amino acid fragment sequence
of a non determined "T. pyriformis-like strain". By using
this incomplete information and data from the entire T.
thermophila  genome it was possible to determine the
whole sequence of the bifunctional DHFR-TS MAC gene
in T. thermophila. The T. thermophila DHFR-TS gene and its
flanking regions were amplified by using the primer pairs
DHFR 5'1F NotI, DHFR 5'2R BamHI for the 5'region non
coding region, the primer pair DHFR 3'1F XhoI: 5, DHFR
3'1R Acc65I for the 3'region and the primers DHFR CDS-
F, DHFR CDS-F for amplification of the coding region.
The T. thermophila DHFR-TS gene structure
The comparison of the amino acid sequences of related
species to the translated coding region of the DHFR-TS
structure gene revealed the corresponding cDNA (see fig-
ure 1). Alignment with the cDNA with the gene revealed
the intron exon boundaries. Figure 1 summarises the
results and shows the MAC gene structure with two
pKOI: The basis for a DHFR-TS knock out construct Figure 3
pKOI: The basis for a DHFR-TS knock out construct. 
Figure 3 shows the knock out construct used for a targeted 
knock out of the DHFR-TS gene in T. thermophila. It consists 
of 3' and 5' flanking regions of the T. thermophila DHFR-TS 
gene and parts of its coding sequence (CDS), disrupted by a 
functional neomycin cassette conferring resistance to paro-
momycin. For more details refer to material and methods 
section.
pKOI
7.7 kb
pKOI
7.7 kb
BamHI
SmaI
EcoRI
EcoRV
XhoI
SacI
Acc65I
NotI
CDS
H4-1prom
NeoR
BTU2 term BTU2 term CDS
3´region
f1 ori f1 ori
AmpR
5´regionBMC Biotechnology 2006, 6:21 http://www.biomedcentral.com/1472-6750/6/21
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introns, the corresponding DNA sequence and the amino
acid sequence of the T. thermophila DHFR-TS.
Sequence alignment of the T. thermophila DHFR-TS 
enzyme to other alveolates
The alignment of the DHFR-TS between the alveolates Tet-
rahymena thermophila, Plasmodium falciparum, Plasmodium
vivax, Cryptosporidium hominis and Toxoplasma gondii (Tt,
Pf, Pv, Ch, Tg in figure 2) illustrates a 50–60% degree of
identity between the proteins. This is also the case if the
ciliate DHFR-TS is compared to the analogous enzyme of
Leishmania major and Trypanosoma cruzi (Lm, Tc in figure
2). This is almost due to the highly conserved thymidylate
synthase part of the bifunctional enzymes. A highly con-
served histidine is found at position 198, suggesting that
the amino acids 198–485 represent the thymidylate syn-
thase part of the bifunctional enzyme. Much more heter-
ogeneity is found in the N-terminal part of the
bifunctional enzyme that consists of the DHFR part and a
linker site. The alignment reveals that almost all enzymes
bear one or more individual, non-homologue amino acid
stretches (figure 2).
Proper integration of the knock out construct into the 
DHFR-TS locus and auxotrophy for thymidine
In order to verify that only one DHFR-TS activity is present
in T. thermophila and that the sequence given in figure 1
corresponds to this activity a construct for knocking out
the DHFR-TS gene was made. By inserting the flanking
regions of the DHFR-TS gene into a pBS II SK backbone we
created a plasmid for stable integration into the ciliate
genome. The neo2  cassette of pH4T2[19] was used to
monitor the successful uptake of this plasmid by selection
against paromomycin. Figure 3 shows that the neo2 cas-
sette is flanked by the ~1.5 kb fragments of the 5' and 3'
parts of the non-coding regions of the DHFR-TS gene,
respectively. Because the pBS backbone lacks an appropri-
ate origin of replication, paromomycin resistant T. ther-
mophila  clones argue for proper homologous
recombination in the DHFR-TS gene locus.
The most convincing evidence for the correct integration
into the DHFR-TS locus is a loss of the DHFR-TS activity
in the transformed strain. However, in the case of T. ther-
mophila  this requires the complete replacement of all
chromosomal DHFR-TS wildtype alleles (~45 ARPs) by
the ARPs that includes the knock out cassette. We
achieved this by allelic assortment, a phenomenon sum-
marised in figure 4. This allelic or phenotypic assortment
is based on randomised distribution of the MAC chromo-
somes units (ARPs) during mitosis. In order to force the
assortment process into the desired direction – namely
into the recombinant resistance gene – the transformed
cells were cultivated for at least 3–4 weeks using increas-
ing concentrations of the drug paromomycin. Single
clones were isolated and tested for DHFR-TS deficiency by
Generation of DHFR-TS deficient strains by allelic assortment Figure 4
Generation of DHFR-TS deficient strains by allelic assortment. Wildtype strains are transfected with pKOI. In one 
copy of the 45 ARPs the endogenous DHFR-TS gene is substituted by the knock out construct (step 2). By amitotic division of 
the MAC and increasing selection pressure clones will arise, that have sorted out all endogenous DHFR-TS genes and retain 
only recombinant and defect DHFR-TS genes (step 3).
transformation
with the pKOI plasmid
allelic / phenotypic
assortment
DHFR-TS
wildtype
DHFR-TS
transformant
DHFR-TS
deficient strain
step I step II step III
wildtype contains the functional
endogenous DHFR-TS gene
(in 45 copies, ARPs)
transformant,
contains at least
one recombinant
DHFR-TS k.o. allel
loss of DHFR-TS activity
because of complete
replacement of the
functional DHFR-TS gene
by the k.o. allelBMC Biotechnology 2006, 6:21 http://www.biomedcentral.com/1472-6750/6/21
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using a minimal chemical defined medium (CDM) with
(+T) and without thymidine (-T). It could be shown that
DHFR-TS knock out clones are real auxotrophic strains.
The mutants are able to grow in CDM with thymidine like
wildtype strains or strains with an incomplete allelic
assortment. In CDM lacking thymidine they are unable to
grow (figure 5).
Functional addition of an expression cassette to the knock 
out construct
The knockout of the endogenous DHFR-TS gene of T. ther-
mophila also provides the possibility to knockin a further
foreign gene that can be expressed heterologously in the
DHFR-TS knock out strains. Therefore we named our con-
structs pKOI (pKOI: knock out and knock in). To illustrate
this knock out/-in concept we constructed the pKOI DVL
plasmid. It consists of a pKOI backbone with an addi-
tional expression cassette that encodes the first 115 amino
acids (aa) of the precursor sequence of the PLA1 gene and
the mature human DNase I (aa 23 to 281). The PLA1 pre/
pro-peptide (aa 1 to 110) has significant similarity to
members of the cathepsin L family and mediates secretion
into the medium[24]. The five additional amino acids (aa
111 to 115) should ensure an optimal cleavage of the pro
PLA1-DNaseI fusion protein by endogenous pro-pepti-
dases. In contrast to the neo2 cassette the expression of the
ppPLA115-DNase I fusion protein is regulated by the
inducible MTT1 promoter[25]. The inducible system was
selected because it allows a clear discrimination between
the DNase activity of heterologously expressed recom-
binant human DNase I and the basal activity due to at
least two endogenous DNases. The transformation, selec-
tion of positive clones and the directed allelic assortment
were done as described in the material and methods sec-
tion.
Furthermore, we tested the correct and complete integra-
tion of both expression cassettes (neo2 and the DNase I)
in the DHFR-TS locus by a PCR approach (figure 6). In
order to demonstrate the pKOI concept, cells of these
DHFR-TS knock out strains carrying the ppPLA115-DNase
expression cassette were treated with and without Cad-
mium. Only induced strains showed an elevated DNase
activity in the supernatant (Figure 7). To confirm this
enzymatic data a specific antiserum against human DNase
I was used to analyse the cell extracts and the supernatant
of these human DNase expressing DHFR-TS knock out
strains by Western blot. The results illustrate that the
DHFR-TS knock out strains are capable of expressing and
secreting the functional recombinant human protein (Fig-
ure 8).
Discussion
The ciliated protozoan T. thermophila features two nuclei,
a somatic macronucleus (MAC) and a genetic micronu-
cleus (MIC) offering different possibilities of manipulat-
Growth of DHFR-TS deficient T. thermophila compared to wildtype Figure 5
Growth of DHFR-TS deficient T. thermophila compared to wildtype. A: Selection of DHFR-TS knock out cells by 
growth on thymidine. T. thermophila cells with disrupted DHFR-TS gene (clone 1–3) do not grow without the presence of thy-
midine (CDM-T), whereas wildtype cells do. Addition of thymidine to the medium (CDM+T) recovers growth. B: Growth 
kinetics of DHFR-TS knock out cells compared to wildtype cells in media with or without thymidine show, that the knock out 
strain (pKOI) is growing as fast as wildtype cells on thymidine supplemented media (CDM+T). Knock out cells die without thy-
midine present (CDM-T). The curves are calculated by mean values of at least three independent experiments.
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Proper integration of DHFR-TS knock out construct Figure 6
Proper integration of DHFR-TS knock out construct. This figure illustrates the PCR approach to determine that the 
knock out/-in construct has integrated into the DHFR-TS gene locus. Three different cells were tested: KI is a wildtype control, 
KII are cells transfected with a plasmid carrying only the disrupting cassettes but no DHFR-TS gene sequences and pKOI DVL 
are cells transformed with the pKOI DVL plasmid. PCR1 is a control reaction amplyfing 369 bp of the beta-hexosaminidase 
gene. PCR2 is to detect endogenous DHFR-TS (note that in the pKOIDVL cells there still is a wildtype gene in the MIC). PCR3 
only yields PCR-product for correctly integrated pKOI DVL DNA. PCR4 shows that the full-length expression cassette has inte-
grated. The first scheme illustrate the overall structure of the DHFR-TS gene, exons are coloured in green and introns in blue. 
The parts of the non-coding 5' and 3' regions of the DHFR-TS structure gene that we used as integration sites in the pKOI/
pKOI DVL plasmids are coloured in grey. The next scheme gives on overall structure of the pKOIDVL expression construct that 
was used for transformation and integration into the MAC. The third scheme illustrates the disruption of the endogenous 
DHFR-TS structure gene by proper integration of the resistance and expression cassettes into the MAC.
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ing the organism's properties (for a short and
comprehensive review see[26]).
It is well known that altering the cell's phenotype ulti-
mately needs direct or indirect (by MIC transformation
and conjugation) genetic engineering of the vegetative
MAC. The first approaches for heterologous expression
were done by using plasmids that use the vast amplifica-
tion of the rDNA gene during anlagen/MAC development.
However, the episomal presence of these plasmids
depends on the drug concentration and the plasmid may
recombine homologously and non-directionally into
endogenous rDNA units.
Stable integration of expression cassettes into diploid MIC
can be achieved by biolistic bombardment. After conjuga-
tion of two different mating types the old MACs disappear
and new ones form that carry the new information
derived from the recombinant MIC. The whole process
follows the statistics of the Mendelian genetics. The
advantage of this approach is that one obtains stable
clones that maintain the genetic properties and that can
be crossed via classical genetics to combine various prop-
erties of different T. thermophila strains. This approach is
elaborative and time consuming. Furthermore, it has been
shown recently that scan RNAs (snRNA) derived from the
old MAC play an important role in DNA elimination dur-
ing the development of the somatic MAC from the germ-
line MIC (see [27] for review). The primary sequence of
these small RNAs explains how the parental MAC epige-
netically controls the genome rearrangement in the new
MAC. In the case of stable MIC transformants this RNAi-
like mechanism may cause partial deletion of foreign
expression cassettes in the developing new MAC [28].
Therefore instead of episomal transformation by rDNA
based plasmids or the stable transformation of the MIC
we used a shortcut by combining MAC transformation
with allelic assortment. This combination has several
advantages. Firstly, the MAC transformation is much
more efficient because there are at least about 45 potential
integration sites per gene locus. This increases the proba-
bility of integration to at least one order of magnitude.
Secondly, not only conjugating but also non-conjugating
and therefore defined strains can be transformed. This is
very important, because it allows the stepwise improve-
ment of strains by maintaining defined genetic properties.
Thirdly after completed allelic assortment the use of any
antibiotic is obsolete as wildtype alleles have vanished in
a one-way-manner. This allows cheap cultivation at large
scales for e.g. biotechnical production processes.
Conclusion
In summary use of the DHFR-TS gene locus as a target for
homologous genomic integration does not only provide a
robust and simple marker system to assure complete
allelic assortment of altered ARPs in the MAC but also the
pKOI concept combining the DHFR-TS knock out with an
additional knock in and subsequent expression of foreign
genes.
Expression of knock in target Figure 8
Expression of knock in target. Western blots show 
expression of recombinant human DNase I: Only trans-
formed and heavy metal induced cells (+) show strong signals 
due to anti-DNase I antibodies. The intracellular PLA1-
DNase-fusion protein is visualized on the left blot by samples 
of cell lysates. Bands are running at higher molecular weight 
than the mature and processed positive control due to the 
pre/pro-peptide. On the right, supernatants were subjected 
to Western blot; the size of the secreted protein of T. ther-
mophila argues for a correct processing when compared to 
the positive control.
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Methods
Cells and cell culture
Tetrahymena thermophila strains B 1868/4, B 1868/7 and B
2068/1 were cultivated in skimmed milk medium[29] in
SPP (0.5% proteose peptone, 0.5% yeast extract, 0.1% fer-
rous sulphate chelate solution and 1% glucose) or in
CDM medium[18].
Amplification of the DHFR-TS gene of T. thermophila
The DHFR-TS cDNA, gene including 5'and 3' flanking
sites can be amplified using the following primer pairs.
Nucleotides in small letters encode sites for restriction
endonucleases. Amplification of the DHFR-TS 5' flanking
region:
DHFR 5'1 F NotI: 5'-cccgcggccgcACAGAGTTAATGGAAAT-
GGAGC-3'
DHFR 5'2R BamHI: 5'-gggggatccATATTTAAGCGATCTT-
TCAATGG-3'
Amplification of the DHFR-TS cDNA and gene with
introns:
DHFR CDS-F:
5'-cgcGAATTCATGAAAACAAGACATTTTGATATAGTTT-
TAGC-3'
DHFR CDS-R:
5'-gcgCTCGAGTCAGACAGCCATTTTCATTTATATTT-
TAGGG-3'
Amplification of the DHFR-TS 3'flanking region:
DHFR 3'1F XhoI: 5'-gggctcgagATGCTCATGTT-
TACTCTAATCACG-3'
DHFR 3'1R Acc65I: 5'-gggggtaccAGTAAAAATAGAGTA-
GAAGGAG-3'.
Construction of plasmids
Construction of pKOI
The pKOI (knock out/-in) plasmid was constructed as fol-
lows: As backbone for selection and propagation in E. coli.
the pBlueScript II SK plasmid was used. The 1.5 kb 5'-
DHFR-TS integration site was amplified using the primer
pair DHFR 5' 1 F NotI and DHFR 5' 2 R BamHI cloned
into pBS II SK by using NotI and BamHI sites. Next the 1.4
kb paromomycin selection cassette from the pH4T2
(neo2)  was cloned into the intermediate pBS IISK by
BamHI and SmaI sites. Finally, the 3'-DHFR-TS integra-
tion site was amplified by primers DHFR 3' 1 F XhoI and
DHFR 3' 1 R Acc65I and cloned by using the XhoI and
Acc65I sites to finish the DHFR-TS knock out cassette. The
SacI site of the pBS II SK backbone had been destroyed by
site directed mutagenesis to facilitate the use of the endog-
enous SacI site in the 3'-DHFR-TS integrating sequence
and the XhoI site as unique cloning site in pKOI. The
whole pKOI basis vector is ~7.7 kb in size and contains a
multiple cloning site (figure 3).
Construction of pKOI DVL
The unique XhoI and SacI sites were used to insert the
ppPLA115-DNase knock in expression cassette (~2.5 kb).
This cassette encodes a fusion protein of the first 115 aa of
the endogenous PLA1 precursor and the aa 23–281 of the
mature human DNaseI, flanked by a ~1 kb MTT1 promo-
tor active sequence and the ~0.4 kb BTU2  terminator,
leading to a ~10.2 kb vector. To ensure proper translation
of this fusion protein a codon optimised synthetic human
DNase I gene was used (submitted at BMC Biotechnol.)
The junction sequence between the MTT1 promoter and
the precursor sequence of PLA1 is given with the sequence
ATGgatatcAAC, using a EcoRV site (gatatc) between the
initial ATG of the MTT1  gene and the second codon
(AAC) of the PLA1 precursor sequence. The cDNA that
encodes the ppPLA115-DNase I fusion protein ends with
the TGA stop codon followed by a BglII site (agatct).
Therefore the "knock in" cassette (generated in an inter-
mediate vector) offers a modular structure that allows the
simple replacement of the promoter (by XhoI/EcoRV), the
coding sequence (by EcoRV/BglII) and the terminator
DNA sequences (by BglII/SacI). Further details of the
primers and constructs are available from the authors.
Transformation of pKOI plasmids (biolistic bombardment)
We used conjugating cells, as well as vegetative, growing
or stationary T. thermophila strains. The transformation of
the  T. thermophila cells was performed as previously
described in[9].
Selection, allelic assortment and DHFR-TS knock out assay
T. thermophila cell proliferation assay: For the first ca 16 h
after biolistic bombardment transformants were grown in
skimmed milk medium. After that transformed cells were
grown on SPP medium with in increasing concentrations
of paromomycin (from 100 µg/mL to 1000 µg/mL) to
support the allelic assortment process. After 3–4 weeks
each clone was cultivated on CDM replica plates with or
without thymidine (10 mg/mL). Functional DHFR-TS
knock out clones are only able to grow in CDM medium
supplemented with thymidine. The viability of the DHFR-
TS knock out strains was monitored by determining the
growth kinetic. The complete integration of the DHFR-TS
knock out and DNase I knock in cassette was confirmed
by PCR using the following primers:BMC Biotechnology 2006, 6:21 http://www.biomedcentral.com/1472-6750/6/21
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DHFR01F: 5'-CTTTTTAACAGCCTGCTGCTCG-3'
DHFR02R: 5'-GATTTTGATGCTTCAATAAGGTTG-3'
DHFR03F: 5'-TTATTTGTTTTATCATAGTGGAAAAGG-3'
DHFR04R: 5'-CAGACACCTCAATCATATCAAAG-3'
DHFR05F: 5'-GGTCCTCCATCAGATTGTGG-3'
DHFR06R: 5'-CGCGTCGAGTCAGACAGCCATTT-
TCATTTA-3'
Hex01F: 5'-ATGCAAAAGATACTTTTAATTACTTTC-3'
Hex02R: 5'-TATATTTTAGGAATGTTGTAATC-3'
A pH4T2 plasmid carrying the same neo2 and DNase I
expression/secretion cassettes was used as PCR control.
SDS-PAGE and Western blot
Aliquots of transformed cells and of SPP supernatants
were resuspended in sample buffer and separated on 15 %
SDS-PAGE. The gels were blotted onto nitrocellulose
membranes and blocked in PBS containing 0.05 % Tween
20 and 5 % skim milk (PBS-TM). The expression of
recombinant human DNase I in transformed Ciliates was
detected by two specific anti sera from rabbit against
human DNase I (antigen: recombinant human DNase I,
Pulmozyme, Roche). Both sera detected the recombinant
DNase I antigen. The serum was used in a 1:500 dilution
in PBS-TM. After washing with PBS/T and applying an
HRP-conjugated anti rabbit serum. The blots were devel-
oped by using chemiluminescence.
DNase I activity assay
The methyl green based DNase activity assay was per-
formed as already published [30]. Samples were incu-
bated at 37°C for 24 h on a microtiter plate. Absorbance
was measured at 620 nm. Calibration of the assay was
achieved by different amounts of defined DNase I Units of
Pulmozyme from Roche (CHO derived) in each experi-
ment and linear regression. These results combined with
semi-quantitative Western blotting were used to calculate
the specific activity of expressed DNase I.
Sequence alignments
DHFR-TS sequences were aligned with Sci Ed Central's
Clonemanger Professional Suite v6.0 using the BLOSUM
62 score matrix.
Authors' contributions
LH evaluated the DHFR-TS targeting sequences, setup and
cloned the pKOI vector system and participated in manu-
script drafting. UB participated in performing the experi-
ments (cloning of pKOI DVL  expression constructs,
transformation and screening of the ciliates, including
monitoring of foreign gene expression) and in figure prep-
aration. MWWH conceived of the study and participated
in its design and coordination. TW participated in project
conception, preparation of figures, did sequence align-
ments and was involved in manuscript drafting. All
authors read and approved the final manuscript.
Acknowledgements
We would like to thank Angelika Kronenfeld for excellent technical assist-
ance and commitment. This work represents main parts of the PhD thesis 
of UB.
References
1. Karrer KM: Tetrahymena genetics: two nuclei are better than
one.  Methods Cell Biol 2000, 62:127-186.
2. Gibbons IR, A.J R: Dynein: a protein with adenosine triphos-
phatase activity from cilia.  Science 1965, 149:424-426.
3. Blackburn EH, Gall JG: A tandemly repeated sequence at the
termini of the extrachromosomal ribosomal RNA genes in
Tetrahymena.  J Mol Biol 1978, 120:33-53.
4. Cech TR, Zaug AJ, Grabowski PJ: In vitro splicing of the ribos-
omal RNA precursor of Tetrahymena: involvement of a gua-
nosine nucleotide in the excision of the intervening
sequence.  Cell 1981, 27:487-496.
5. Greider CW, Blackburn EH: Identification of a specific telomere
terminal transferase activity in Tetrahymena extracts.  Cell
1985, 43:405-413.
6. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY,
Allis CD: Tetrahymena histone acetyltransferase A: a
homolog to yeast Gcn5p linking histone acetylation to gene
activation.  Cell 1996, 84:843-851.
7. Pan WC, Blackburn EH: Single extrachromosomal ribosomal
RNA gene copies are synthesized during amplification of the
rDNA in Tetrahymena.  Cell 1981, 23:459-466.
8. Gaertig J, Gorovsky MA: Efficient mass transformation of Tet-
rahymena thermophila by electroporation of conjugants.
Proc Natl Acad Sci U S A 1992, 89:9196-9200.
9. Cassidy-Hanley D, Bowen J, Lee JH, Cole E, VerPlank LA, Gaertig J,
Gorovsky MA, Bruns PJ: Germline and somatic transformation
of mating Tetrahymena thermophila by particle bombard-
ment.  Genetics 1997, 146:135-147.
10. Larson DD, Blackburn EH, Yaeger PC, Orias E: Control of rDNA
replication in Tetrahymena involves a cis-acting upstream
repeat of a promoter element.  Cell 1986, 47:229-240.
11. Hai B, Gaertig J, Gorovsky MA: Knockout heterokaryons enable
facile mutagenic analysis of essential genes in Tetrahymena.
Methods Cell Biol 2000, 62:513-531.
12. Gaertig J, Kapler G: Transient and stable DNA transformation
of Tetrahymena thermophila by electroporation.  Methods Cell
Biol 2000, 62:485-500.
13. Clark TG, Gao Y, Gaertig J, Wang X, Cheng G: The I-antigens of
Ichthyophthirius multifiliis are GPI-anchored proteins.  J
Eukaryot Microbiol 2001, 48:332-337.
14. Peterson DS, Gao Y, Asokan K, Gaertig J: The circumsporozoite
protein of Plasmodium falciparum is expressed and localized
to the cell surface in the free-living ciliate Tetrahymena ther-
mophila.  Mol Biochem Parasitol 2002, 122:119-126.
15. Sweeney R, Fan Q, Yao MC: Antisense ribosomes: rRNA as a
vehicle for antisense RNAs.  P r o c  N a t l  A c a d  S c i  U  S  A  1996,
93:8518-8523.
16. Guberman A, Hartmann M, Tiedtke A, Florin-Christensen J, Florin-
Christensen M: A method for the preparation of Tetrahymena
thermophila phospholipase A1 suitable for large-scale pro-
duction.  J Appl Microbiol 1999, 86:226-230.
17. Wheatley DN, Rasmussen L, Tiedtke A: Tetrahymena: a model
for growth, cell cycle and nutritional studies, with biotechno-
logical potential.  Bioessays 1994, 16:367-372.
18. Hellenbroich D, Valley U, Ryll T, Wagner R, Tekkanat N, Kessler W,
Ross A, Deckwer WD: Cultivation of Tetrahymena ther-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Biotechnology 2006, 6:21 http://www.biomedcentral.com/1472-6750/6/21
Page 11 of 11
(page number not for citation purposes)
mophila in a 1.5-m3 airlift bioreactor.  Appl Microbiol Biotechnol
1999, 51:447-455.
19. Gaertig J, Gu L, Hai B, Gorovsky MA: High frequency vector-
mediated transformation and gene replacement in Tetrahy-
mena.  Nucleic Acids Res 1994, 22:5391-5398.
20. Gaertig J, Thatcher TH, Gu L, Gorovsky MA: Electroporation-
mediated replacement of a positively and negatively selecta-
ble beta-tubulin gene in Tetrahymena thermophila.  Proc Natl
Acad Sci U S A 1994, 91:4549-4553.
21. Huennekens FM: The methotrexate story: a paradigm for
development of cancer chemotherapeutic agents.  Adv Enzyme
Regul 1994, 34:397-419.:397-419.
22. Stechmann A, Cavalier-Smith T: Rooting the eukaryote tree by
using a derived gene fusion.  Science 2002, 297:89-91.
23. The Institute for Genomic Research.  [ http://www.tigr.org ]. 
24. Weide T, Herrmann L, Bockau U, Niebur N, Aldag I, Laroy W, Con-
treras A, Tiedtke A, Hartmann MWW: Secretion of functional
human enzymes by Tetrahymena thermophila.  BMC Biotech-
nol 2006, 6:19.
25. Shang Y, Song X, Bowen J, Corstanje R, Gao Y, Gaertig J, Gorovsky
MA: A robust inducible-repressible promoter greatly facili-
tates gene knockouts, conditional expression, and overex-
pression of homologous and heterologous genes in
Tetrahymena thermophila.  Proc Natl Acad Sci U S A 2002,
99:3734-3739.
26. Collins K, Gorovsky MA: Tetrahymena thermophila.  Curr Biol
2005, 15:R317-R318.
27. Yao MC, Chao JL: RNA-Guided DNA Deletion in Tetrahy-
mena: An RNAi-Based Mechanism for Programmed
Genome Rearrangements.  Annu Rev Genet 2005, .:.
28. Yao MC, Fuller P, Xi X: Programmed DNA deletion as an RNA-
guided system of genome defense.  Science 2003,
300:1581-1584.
29. Kiy T, Tiedtke A: Continuous high-cell-density fermentation of
the ciliated protozoon Tetrahymena in a perfused bioreac-
tor.  Appl Microbiol Biotechnol 1992, 38:141-146.
30. Sinicropi D, Baker DL, Prince WS, Shiffer K, Shak S: Colorimetric
determination of DNase I activity with a DNA-methyl green
substrate.  Anal Biochem 1994, 222:351-358.